Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events

Arthritis and Rheumatism

Volumn 64, Issue 2, 2012, Pages 504-512

  Otomo, Kotaro ^a   Atsumi, Tatsuya ^a   Amengual, Olga ^a   Fujieda, Yuichiro ^a   Kato, Masaru ^a   Oku, Kenji ^a   Horita, Tetsuya ^a   Yasuda, Shinsuke ^a   Koike, Takao ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; BETA2 GLYCOPROTEIN 1 ANTIBODY; CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LUPUS ANTICOAGULANT; PHOSPHATIDYLSERINE; PHOSPHOLIPID ANTIBODY; PROTHROMBIN ANTIBODY;

ANTIPHOSPHOLIPID SCORE; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; DIAGNOSTIC VALUE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE; PREGNANCY DISORDER; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOSIS;

ADULT; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PROTHROMBIN; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 84856371421     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.33340     Document Type: Article

References (48)

1. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4: 295-306.
2. Pierangeli SS, Harris EN,. A quarter of a century in anticardiolipin antibody testing and attempted standardization has led us to here, which is? Semin Thromb Hemost 2008; 34: 313-28.
3. Koike T, Sueishi M, Funaki H, Tomioka H, Yoshida S,. Anti-phospholipid antibodies and biological false positive serological test for syphilis in patients with systemic lupus erythematosus. Clin Exp Immunol 1984; 56: 193-9. (Pubitemid 14161205)
4. Harris EN, Gharavi AE, Tincani A, Chan JK, Englert H, Mantelli P, et al. Affinity purified anti-cardiolipin and anti-DNA antibodies. J Clin Lab Immunol 1985; 17: 155-62. (Pubitemid 16244232)
5. Galli M, Comfurius P, Maassen C, Hemker HC, de Baets MH, van Breda-Vriesman PJ, et al. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet 1990; 335: 1544-7. (Pubitemid 20189625)
6. Matsuura E, Igarashi Y, Fujimoto M, Ichikawa K, Koike T,. Anticardiolipin cofactor(s) and differential diagnosis of autoimmune disease. Lancet 1990; 336: 177-8. (Pubitemid 20225005)
7. 2-glycoprotein I (apolipoprotein H). Proc Natl Acad Sci U S A 1990; 87: 4120-4.
8. 2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface. J Exp Med 1994; 179: 457-62. (Pubitemid 24058733)
9. 2-glycoprotein I for binding of anticardiolipin antibodies to cardiolipin. Lancet 1990; 336: 952-3. (Pubitemid 20351230)
10. Loeliger A,. Prothrombin as a co-factor of circulating anticoagulant in systemic lupus erythematosus? Thromb Diath Haemorrh 1959; 3: 237-56.
11. Fleck RA, Rapaport SI, Rao LV,. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988; 72: 512-9.
12. Bevers EM, Galli M, Barbui T, Comfurius P, Zwaal RF,. Lupus anticoagulant IgG's (LA) are not directed to phospholipids only, but to a complex of lipid-bound human prothrombin. Thromb Haemost 1991; 66: 629-32.
13. Oosting JD, Derksen RH, Bobbink IW, Hackeng TM, Bouma BN, de Groot PG,. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C, or protein S: an explanation for their pathogenic mechanism? Blood 1993; 81: 2618-25. (Pubitemid 23147565)
14. Arvieux J, Darnige L, Caron C, Reber G, Bensa JC, Colomb MG,. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995; 74: 1120-5.
15. Galli M,. Should we include anti-prothrombin antibodies in the screening for the antiphospholipid syndrome? J Autoimmun 2000; 15: 101-5.
16. Atsumi T, Ieko M, Bertolaccini ML, Ichikawa K, Tsutsumi A, Matsuura E, et al. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and with the presence of lupus anticoagulant. Arthritis Rheum 2000; 43: 1982-93.
17. Matsuda J, Saitoh N, Gotoh M, Kawasugi K, Gohchi K, Tsukamoto M,. Phosphatidyl serine-dependent antiprothrombin antibody is exclusive to patients with lupus anticoagulant. Br J Rheumatol 1996; 35: 589-91.
18. Galli M, Beretta G, Daldossi M, Bevers EM, Barbui T,. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Thromb Haemost 1997; 77: 486-91. (Pubitemid 27121014)
19. Brandt JT, Triplett DA, Alving B, Scharrer I,. Criteria for the diagnosis of lupus anticoagulants: an update. On behalf of the Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the ISTH. Thromb Haemost 1995; 74: 1185-90.
20. Harris EN, Gharavi AE, Patel BM, Hughes GR,. Evaluation of the anti-cardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 215-22. (Pubitemid 17044795)
21. 2-glycoprotein I in patients with antiphospholipid syndrome. Br J Rheumatol 1996; 35: 1239-43.
22. Amengual O, Atsumi T, Khamashta MA, Hughes GR,. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost 1998; 79: 276-81. (Pubitemid 28065869)
23. Atsumi T, Khamashta MA, Haworth RS, Brooks G, Amengual O, Ichikawa K, et al. Arterial disease and thrombosis in the antiphospholipid syndrome: a pathogenic role for endothelin 1. Arthritis Rheum 1998; 41: 800-7.
24. Pierangeli SS, Espinola RG, Liu X, Harris EN,. Thrombogenic effects of antiphospholipid antibodies are mediated by intercellular cell adhesion molecule-1, vascular cell adhesion molecule-1, and P-selectin. Circ Res 2001; 88: 245-50. (Pubitemid 32147315)
25. 2Glycoprotein I antibodies. Int Immunol 2004; 16: 1633-41. (Pubitemid 39480782)
26. 2-glycoprotein I on thrombin-mediated factor XIa generation. Arthritis Rheum 2007; 56: 605-13.
27. Sakai Y, Atsumi T, Ieko M, Amengual O, Furukawa S, Furusaki A, et al. The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation. Arthritis Rheum 2009; 60: 2457-67.
28. Horbach DA, van Oort E, Donders RC, Derksen RH, de Groot PG,. Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systemic lupus erythematosus: comparison between different assays for the detection of antiphospholipid antibodies. Thromb Haemost 1996; 76: 916-24.
29. Galli M, Luciani D, Bertolini G, Barbui T,. Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature. Blood 2003; 101: 1827-32. (Pubitemid 36237580)
30. Galli M, Reber G, de Moerloose P, de Groot PG,. Invitation to a debate on the serological criteria that define the antiphospholipid syndrome. J Thromb Haemost 2008; 6: 399-401.
31. Shoenfeld Y, Twig G, Katz U, Sherer Y,. Autoantibody explosion in antiphospholipid syndrome. J Autoimmun 2008; 30: 74-83.
32. Sanmarco M,. Clinical significance of antiphosphatidylethanolamine antibodies in the so-called "seronegative antiphospholipid syndrome". Autoimmun Rev 2009; 9: 90-2.
33. 2-glycoprotein I antibodies in children with atopic dermatitis. Int Immunol 2002; 14: 823-30. (Pubitemid 34814643)
34. Giron-Gonzalez JA, Garcia del Rio E, Rodriguez C, Rodriguez-Martorell J, Serrano A,. Antiphospholipid syndrome and asymptomatic carriers of antiphospholipid antibody: prospective analysis of 404 individuals. J Rheumatol 2004; 31: 1560-7. (Pubitemid 39006638)
35. Pengo V, Biasiolo A, Gresele P, Marongiu F, Erba N, Veschi F, et al. Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples. J Thromb Haemost 2007; 5: 925-30. (Pubitemid 46691720)
36. Tincani A, Taraborelli M, Cattaneo R,. Antiphospholipid antibodies and malignancies. Autoimmun Rev 2010; 9: 200-2.
37. Biggioggero M, Meroni PL,. The geoepidemiology of the antiphospholipid antibody syndrome. Autoimmun Rev 2010; 9: A299-304.
38. Roubey RA,. Risky business: the interpretation, use, and abuse of antiphospholipid antibody tests in clinical practice. Lupus 2010; 19: 440-5.
39. Erkan D, Espinosa G, Cervera R,. Catastrophic antiphospholipid syndrome: updated diagnostic algorithms. Autoimmun Rev 2010; 10: 74-9.
40. Tincani A, Filippini M, Scarsi M, Galli M, Meroni PL,. European attempts for the standardisation of the antiphospholipid antibodies. Lupus 2009; 18: 913-9.
41. Tincani A, Allegri F, Sanmarco M, Cinquini M, Taglietti M, Balestrieri G, et al. Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations-a cooperative project of the European Antiphospholipid Forum. Thromb Haemost 2001; 86: 575-83. (Pubitemid 32743269)
42. De Groot PG, Derksen RH, de Laat B,. Twenty-two years of failure to set up undisputed assays to detect patients with the antiphospholipid syndrome. Semin Thromb Hemost 2008; 34: 347-55.
43. Urbanus RT, Siegerink B, Roest M, Rosendaal FR, de Groot PG, Algra A,. Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol 2009; 8: 998-1005.
44. Naess IA, Christiansen SC, Cannegieter SC, Rosendaal FR, Hammerstroem J,. A prospective study of anticardiolipin antibodies as a risk factor for venous thrombosis in a general population (the HUNT study). J Thromb Haemost 2006; 4: 44-9.
45. De Groot PG, Lutters B, Derksen RH, Lisman T, Meijers JC, Rosendaal FR,. Lupus anticoagulants and the risk of a first episode of deep venous thrombosis. J Thromb Haemost 2005; 3: 1993-7. (Pubitemid 43086056)
46. Pengo V, Ruffatti A, Legnani C, Gresele P, Barcellona D, Erba N, et al. Clinical course of high-risk patients diagnosed with antiphospholipid syndrome. J Thromb Haemost 2010; 8: 237-42.
47. Atsumi T, Koike T,. Antiprothrombin antibody: why do we need more assays? Lupus 2010; 19: 436-9.
48. Oku K, Atsumi T, Amengual O, Koike T,. Antiprothrombin antibody testing: detection and clinical utility. Semin Thromb Hemost 2008; 34: 335-9.